OK, now this makes some sort of sense - but it is not to do with the patent these people are citing! If they wanted to talk about this aspect, then this would be a more relevant patent:
http://www.google.com/patents/EP1112360A1?cl=en
This is new stuff to me (and although I studied chemistry, that is a world away from genetics and biochem!) but it appears that this insect hormone, ecdysone, can be used to trigger protein manufacture in mammal (and human) cells for
gene therapy.
Normally, humans don't have a receptor for ecdysone, so it can be used as a targeted "switch". The idea is that you introduce the genetic coding for an ecdysone receptor into the cells, along with the genetic coding to create some other protein which will have therapeutic effects.
When you then introduce ecdysone (or a similar steroid that can bind to an ecdysone receptor), it will act as a switch to turn on production of the other protein.
This is a link to a commercial application of the technology:
http://www.genomics.agilent.com/article.jsp?pageId=496&_requestid=937758
So, in summary:
Yes, ecdysone receptors are being used in gene therapy. But this is just one method of turning on the gene expression, and ecdysone by itself just acts as the switch to cause "a gene" to be turned on. Nowhere in any of this is there any evidence for the supposed artificial gene that is being switched on to cause Morgellons!
If I can suggest an analogy, it is like using a patent for a new kind of surgical scalpel as evidence that mad doctors are going to cut out everybody's livers.
I would also take issue with the use of this very misleading image:
Polynucleotides are indeed DNA and RNA, but in the sense of this patent they are simply genes that express the ecdysone receptor protein. This picture is clearly intended to imply that they are instead some form of polymer fibre such as Morgellons "sufferers" pull from their skin.
Honestly, who sits down and comes up with this stuff, and why?